Periprocedural anticoagulation. (A) Bridging strategy suggested in the clinical trial protocol for low-risk patients. (B) Bridging strategy suggested in the clinical trial protocol for intermediate- and high-risk patients. INR, international normalized ratio; LMWH, low-molecular-weight heparin; POC, point of care; UFH, unfractionated heparin.